What is already known
- Coneal injury is a common eye disease which may result in
vision-threatening situation.
- Epidermal growth factor involves corneal healing, which may be a
therapeutic option of corneal injury.
- Human recombinant epidermal growth factor eyedrops have shown the
effect in vitro and animal study in the treatment of corneal injury,
however, there are no published human data.